Dorzolamide hydrochloride and timolol maleate
Dorzolamide Hydrochloride and Timolol Maleate is a prescription eye drop solution used to lower pressure inside the eye, often for treating glaucoma or ocular hypertension. It combines two medications: dorzolamide (a carbonic anhydrase inhibitor) and timolol (a beta-blocker) to reduce fluid production in the eye. Manufactured by Somerset Therapeutics, LLC, it's available as a 10 mL bottle. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dorzolamide Hydrochloride and Timolol Maleate is a prescription eye drop solution used to lower pressure inside the eye, often for treating glaucoma or ocular hypertension. It combines two medications: dorzolamide (a carbonic anhydrase inhibitor) and timolol (a beta-blocker) to reduce fluid production in the eye. Manufactured by Somerset Therapeutics, LLC, it's available as a 10 mL bottle. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dorzolamide hydrochloride and timolol maleate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dorzolamide hydrochloride and timolol maleate — ANDA 207523 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207523"
}
]
|
| identifier | ANDA207523 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"health-care",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dorzolamide hydrochloride and timolol maleate |
